http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-122007000051-I1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
filingDate 1998-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-122007000051-I1
titleOfInvention Crystal modification of 1- (2,6-difluorobenzyl) -1H-1,2,3, triazole-4-carboxylic acid ureamide and its use as an antiepileptic
priorityDate 1997-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419706622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140120

Total number of triples: 16.